Led multidisciplinary team to develop minimally invasive transendocardial delivery catheter and adjunctive technologies (augmented imaging software, steerable sheath), configure and test combination products, build surgical procedure, and manage system integration. Established and managed strategic external partnerships.

Developed combination products consisting of cardiac drug delivery catheters and cellular therapeutics. Used for transendocardial drug delivery into the left ventricle to treat heart failure.

Developed drug-device combination products for injectable biologics, focusing on reusable and single-use subcutaneous autoinjectors. Served as Risk Manager and Systems Engineer.

Supported commercial lifecycle management of minimally invasive hemodynamic monitoring sensors (FloTrac, VolumeView) and atrioseptostomy balloon catheters (Fogarty, Miller).

Developed implantable cardiac pacing leads used with pacemakers and implantable cardioverter-defibrillator (ICDs). Served on the advanced technology group, responsible for creating novel technologies and integrating them into product platforms.